| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10011590 | Journal of the American Academy of Dermatology | 2005 | 6 Pages |
Abstract
In this preliminary open label study topical imiquimod 5% cream was well tolerated and associated with a histologic and clinical response rate of 50%.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Matthew J. MD, PhD, James T. MD, Robert P. MD, PhD, Chan MS, John L. MD,